Evaluation of Interleukin-17 serum levels in patients with chronic myeloproliferative diseases

Tumori

Volumn 95, Issue 3, 2009, Pages 404-405

  Allegra, Alessandro ^a   Alonci, Andrea ^a   Bellomo, Giacomo ^a   D'Angelo, Arianna ^a   Granata, Angela ^a   Russo, Sabina ^a,b   Quartarone, Eugenia ^a   Musolino, Caterina ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17;

ADULT; BONE MARROW BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LETTER; MALE; MYELOID METAPLASIA; PATHOGENESIS; POLYCYTHEMIA VERA; PROTEIN BLOOD LEVEL; THROMBOCYTHEMIA;

SERUM LEVELS;

FOOD TECHNOLOGY;

EID: 67849094001     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160909500326     Document Type: Letter

References (18)

1. Gaffen SL, Kramer JM, Yu JJ, Shen F: The IL-17 cytokine family. Vitam Horm, 74: 255-282, 2006.
2. Beerepoot LV, Mehra N, Vermmat JSP, Zonnbenberg BA, Gebbink MFGB, Voest EE: Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients. Ann Oncol, 15: 139-145, 2004. (Pubitemid 38139616)
3. Pelosi E, Valtieri M, Coppola S, Botta R, Gabbianelli M, Lulli V: Identification of the hemangioblast in postnatal life. Blood, 100: 3203-3208, 2002.
4. Ciree A, Michel L, Camilleri-Broet S, Jean Lous F, Oster M, Flageul B, Senet P, Fossiez F, Fridman WH, Bachelez H, Tartour E: Expression and activity of IL-17 in cutaneous T cell lymphomas (mycosis fungoides and Sezary syndrome). Int J Cancer, 112: 113-120, 2004. (Pubitemid 39249498)
5. Starnes T, Robertson MJ, Sledge G, Kelich S, Nakshatri H, Broxmeyer HE, Hromas R: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production. J Immunol, 167: 4137-4140, 2001. (Pubitemid 32954284)
6. Numasaki M, Tomioka Y, Takahashi H, Sasaki H: IL-17 and IL-17F modulate GM-CSF production by lung microvascular endothelial cells stimulated with IL-1 alpha and/or TNF-alpha. Immunol Lett, 95: 175-184, 2004. (Pubitemid 39237663)
7. Numasaki M, Fukushi J, Ono M, Narula SK, Zavodny PJ, Kudo T, Robbins PD, Tahara H, Lotze MT: Interleukin-17 promotes angiogenesis and tumor growth. Blood, 101: 2620-2627, 2003. (Pubitemid 36857622)
8. Aleksandrakis MG, Pappa CA, Miyakis S, Sfiridaki A, Kafousi M, Alegakis A, Stathopoulos EN: Serum interleukin-17 and its relationship to angiogenic factors in multiple myeloma. Eur J Int Med, 17: 412-416, 2006.
9. Tartour E, Fossiez F, Joyeux I, Galinha A, Gey A, Claret E, Sastre-Garau X, Couturier J, Mosseri V, Vives V: Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res, 59: 3698-3704, 1999.
10. Benchetrit F, Ciree A, Vives V, Warnier G, Gey A, Sautes-Fridman C, Fossiez F, Haicheur N, Fridman WH, Tartour E: Interleukin-17 inhibits tumor cell growth by means of a T-cell-dependent mechanism. Blood, 99: 2114-2121, 2002.
11. Zhou L, Peng S, Duan J, Zhou J, Wang L, Wang J: A human B cell line AF10 expressing HIL-17. Biochem Mol Biol Int, 45: 1113-1119, 1998.
12. Wrobel T, Mazur G, Jazwiec B, Kuliczkowski K: Interleukin-17 in acute myeloid leukaemia. J Cell Mol Med, 7: 472-474, 2003.
13. Numasaki M, Tomioka Y, Takahashi H, Sasaki H: IL-17 and IL-17F modulate GM-CSF production by lung microvascular endothelial cells stimulated with IL-1beta and/or TNF-alpha. Immunol Lett, 95: 175-184, 2004.
14. Dai CH, Krantz SB, Dessypris EN, Meens RT Jr, Horn ST, Gilbert HJ: Polycythemia vera. II. Hypersensitivity of bone marrow erythroid, granulocyte-macrophage, and megakaryocyte progenitor cells to interleukin-3 and granulocytemacrophage colony-stimulating factor. Blood, 80: 891-899, 2002.
15. Jovcic G, Bugarski D, Patakov M, Krstic A, Vlaski M, Stojanovic N, Milenkovic P: In vivo effects of interleukin-17 on haematopoietic cells and cytokine release in normal mice. Cell Prolif, 37: 401-412, 2004.
16. Starnes T, Broxmeyer HE, Robertson MJ, Hronas R: Cutting edge: IL-17 a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J Immunol, 169: 642-646, 2002.
17. Boveri E, Passamonti F, Umi E, Pietra D, Elena C, Arcaini L, Pascutto C, Castello A, Cazzola M, Magrini V, Lazzarino M: Bone marrow microvessel density in chronic myeloproliferative disorders. A study of 115 patients with clinicopathological and molecular correlations. Br J Haematol, 140: 162-168, 2008.
18. Panteli K, Bai M, Hstzmichael E, Zagorianakov N, Agnantis NJ, Bourantes K: Serum levels and bone marrow immunohistochemical expression of vascular endothelial growth factor in patients with chronic myeloproliferative diseases. Haematology, 1: 155-158, 2007.